日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis

治疗方案中包含阿伐可潘(Avacopan)治疗显微镜下多血管炎引起的胆管消失综合征

Hishinuma, Mako; Hasegawa, Midori; Minatoguchi, Shun; Umeda, Ryosuke; Koide, Shigehisa; Hayashi, Hiroki; Yuzawa, Yukio; Minamiguchi, Sachiko; Tsuboi, Naotake

Dapagliflozin use in tolvaptan-treated patients with ADPKD: exploring renal outcomes in a retrospective study

在接受托伐普坦治疗的ADPKD患者中使用达格列净:一项回顾性研究探讨其肾脏结局

Nakajima, Ryunosuke; Minatoguchi, Shun; Umeda, Ryosuke; Koide, Shigehisa; Hasegawa, Midori; Hayashi, Hiroki; Tsuboi, Naotake

Investigation of the Impact of Tryptophan-Metabolizing Enzymes and Kynurenic Acid on Antibody-Mediated Glomerulonephritis.

研究色氨酸代谢酶和犬尿酸对抗体介导的肾小球肾炎的影响

Umeda Ryosuke, Ito Yoshimasa, Minatoguchi Shun, Koide Shigehisa, Takahashi Kazuo, Hayashi Hiroki, Hasegawa Midori, Yuzawa Yukio, Yamamoto Yasuko, Saito Kuniaki, Tsuboi Naotake

Risk factors of peritoneal dialysis-related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

日本腹膜透析结果和实践模式研究(PDOPPS)中腹膜透析相关性腹膜炎的危险因素

Ito, Yasuhiko; Tu, Charlotte; Yamaguchi, Makoto; Koide, Shigehisa; Ryuzaki, Munekazu; Bieber, Brian; Pisoni, Ronald L; Perl, Jeffrey; Minakuchi, Jun; Kawanishi, Hideki

Additional renoprotective effect of the SGLT2 inhibitor dapagliflozin in a patient with ADPKD receiving tolvaptan treatment

在接受托伐普坦治疗的ADPKD患者中,SGLT2抑制剂达格列净具有额外的肾脏保护作用

Minatoguchi, Shun; Hayashi, Hiroki; Umeda, Ryosuke; Koide, Shigehisa; Hasegawa, Midori; Tsuboi, Naotake

Combination of brain natriuretic peptide and urinary albumin as a predictor of cardiovascular-renal events in outpatients with chronic kidney disease

脑钠肽和尿白蛋白联合检测作为慢性肾脏病门诊患者心血管肾脏事件的预测指标

Oyama, Shoya; Takahashi, Hiroshi; Hayashi, Hiroki; Koide, Shigehisa; Nakai, Shigeru; Takahashi, Kazuo; Inaguma, Daijo; Hasegawa, Midori; Ishii, Junichi; Yuzawa, Yukio; Tsuboi, Naotake

Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell-free and concentrated ascites reinfusion therapy, in a postmarketing clinical study

在上市后临床研究中评估新型无细胞浓缩腹水回输治疗设备 Plasauto μ 的性能、可操作性和安全性

Hasegawa, Midori; Matsushita, Hiromichi; Yahata, Kensei; Sugawara, Akira; Ishibashi, Yoshitaka; Kawahara, Ryoko; Hamasaki, Yoshifumi; Kanno, Hitoshi; Yamada, Sachie; Nii, Norio; Kato, Masao; Ohashi, Atsushi; Koide, Shigehisa; Hayashi, Hiroki; Yuzawa, Yukio; Tsuboi, Naotake

Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study

极度高尿酸血症是新发透析患者感染相关死亡的危险因素:一项多中心前瞻性队列研究

Yoshida, Hiroyuki; Inaguma, Daijo; Koshi-Ito, Eri; Ogata, Soshiro; Kitagawa, Akimitsu; Takahashi, Kazuo; Koide, Shigehisa; Hayashi, Hiroki; Hasegawa, Midori; Yuzawa, Yukio; Tsuboi, Naotake

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients

预测新发透析患者心血管事件或全因死亡率的模型

Inaguma, Daijo; Morii, Daichi; Kabata, Daijiro; Yoshida, Hiroyuki; Tanaka, Akihito; Koshi-Ito, Eri; Takahashi, Kazuo; Hayashi, Hiroki; Koide, Shigehisa; Tsuboi, Naotake; Hasegawa, Midori; Shintani, Ayumi; Yuzawa, Yukio

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis

主动脉瓣狭窄是透析患者全因死亡率的危险因素:一项多中心前瞻性队列分析

Inaguma, Daijo; Sasakawa, Yuji; Suzuki, Noriko; Ito, Eri; Takahashi, Kazuo; Hayashi, Hiroki; Koide, Shigehisa; Hasegawa, Midori; Yuzawa, Yukio